Outcomes of salvage lung resections in advanced EGFR-mutant lung adenocarcinomas under EGFR TKIs,Thoracic Cancer

当前位置： X-MOL 学术 › Thorac. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Outcomes of salvage lung resections in advanced EGFR-mutant lung adenocarcinomas under EGFR TKIs
Thoracic Cancer ( IF 2.3 ) Pub Date : 2021-09-08 , DOI: 10.1111/1759-7714.13646
Ying-Yuan Chen _{1,

2} , Yi-Ting Yen ₁ , Wu-Wei Lai ₁ , Wei-Li Huang _{1,

2} , Chao-Chun Chang ₁ , Yau-Lin Tseng ₁

Affiliation

Studies regarding the outcomes of salvage lung resections of epidermal growth factor receptor (EGFR)-mutant advanced lung adenocarcinomas (ALAs) following treatment with EGFR tyrosine kinase inhibitors (TKIs) are limited, hence the objective of this study was to investigate such outcomes.

中文翻译：